Lexicon Pharmaceuticals Inc (LXRX)
0.8244
+0.11
(+15.35%)
USD |
NASDAQ |
Dec 23, 16:00
0.82
0.00 (0.00%)
After-Hours: 19:33
Lexicon Pharmaceuticals Cash from Investing (Quarterly): 53.47M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viatris Inc | 1.748B |
| Halozyme Therapeutics Inc | -167.48M |
| Perspective Therapeutics Inc | -29.74M |
| Quanterix Corp | 6.975M |
| Autonomix Medical Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -53.62M |
| Cash from Financing (Quarterly) | -0.916M |
| Free Cash Flow | -208.39M |
| Free Cash Flow Per Share (Quarterly) | -0.1492 |
| Free Cash Flow to Equity (Quarterly) | -54.32M |
| Free Cash Flow Yield | -86.95% |